**Abstract**

Cytokine levels were generally changed in both depressed patients and animal models. Altered peptide ligand (APL) of myelin basic protein (MBP) regulates levels of various cytokines, and MBP~87--99~\[A^91^\] ameliorated depressive behavior in rats. In this study, we aimed to evaluate the potential antidepressant effects of various APLs of MBP. We found that a single dose of either MBP~87-99~\[A91, A96\] or MBP~87-99~\[R91, A96\] produced a prolonged antidepressant-like effect by reducing the immobility in the forced swim test (FST) and preventing chronic unpredictable stress (CUS)-induced anhedonia. However, MBP~87-99~\[R^91^, A^96^\] also increased latency to feed in novelty suppressed feeding test, indicating its possible pro-anxiety effect. Application of these peptides increased c-fos expression in the medial prefrontal cortex (mPFC) and dentate gyrus (DG) after FST assessed by immunohistochemistry. MBP~87-99~\[A^91^, A^96^\] prevented CUS-induced decrease in p11 and BDNF in mPFC, and p11, BDNF and pCREB in DG, and MBP~87-99~\[R^91^, A^96^\] prevented CUS-induced decrease in BDNF in mPFC, and p11 in DG. Moreover, intra-mPFC infusion of lentiviral vectors containing short-hairpin RNA targeting p11 (LV~p11-shRNA~) inhibited the expression of p11, and blunted the antidepressant-like effects of MBP~87-99~\[A^91^, A^96^\] in rats subjected to FST and CUS. Altogether, our results indicate that MBP~87-99~\[A^91^, A^96^\] produced prolonged antidepressant-like effects in rats, and the behavioral response is mediated by p11 signaling in the mPFC. Immune-based therapeutic strategies have the potential for depression treatment.
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